Box
Latest Eli Lilly and Company Patents:
The file of this patent contains at least one drawing executed in color. Copies of this patent with color drawings will be provided by the Office upon request and payment of the necessary fee.
The broken lines of even length illustrate portions of the box and form no part of the claimed design.
Claims
The ornamental design for a box, as shown and described.
| D496275 | September 21, 2004 | Hamuro |
| D802415 | November 14, 2017 | Wilcox |
| D842097 | March 5, 2019 | Huggins |
| D867337 | November 19, 2019 | Kitamura |
| D955215 | June 21, 2022 | Kozub |
| 002028217-0007 | April 2012 | EM |
| 015070251-0003 | March 2025 | EM |
| 2024-006944 | December 2024 | TR |
- FDA approves a second Alzheimer's drug, Eli Lilly's Kisunla | AP News. Date first available: Jul. 2, 2024. Site visited: Sep. 8, 2025. Available online: https://apnews.com/article/alzheimers-drug-kisunla-leqembi-donanemab-fd804c1271ae185a62f080e072d21698 (Year: 2024).
- Doctor talks about FDA. 's approval of second Alzheimer's drug that can modestly slow disease—YouTube. Date first available: Jul. 3, 2024. Site visited: Sep. 8, 2025. Available online: https://www.youtube.com/watch?v=FxTAq1HV_OY (Year: 2024).
Type: Grant
Filed: Feb 27, 2024
Date of Patent: Nov 3, 2026
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventors: Doris Dell (New York, NY), Fernando Fernandez (Maplewood, NJ), Reina Katsui (New York, NY), Robert Schroeder (Westfield, NJ), Stacy Miller (Fishers, IN), Monica Claire Popp (Indianapolis, IN)
Primary Examiner: Andrew Kerr
Assistant Examiner: Joan E. Diehl
Application Number: 29/930,061